Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | HTR2B | P41595 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.44 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL50970 | 0.96 | TRPA1 (0.57) | TRPA1LMNACHRM1ADRA1ASLC6A2 | |
| SCHEMBL1758427 | 0.86 | TRPA1 (0.63) | TRPA1LMNACHRM1ADRA1ASLC6A2 | |
| SCHEMBL11954775 | 0.85 | LMNA (0.57) | TRPA1LMNACHRM1ADRA1ASLC6A2 | |
| SCHEMBL28499022 | 0.85 | CHRM1 (0.55) | TRPA1LMNACHRM1ADRA1ASLC6A2 | |
| SCHEMBL7012899 | 0.83 | CHRM1 (0.55) | TRPA1LMNACHRM1ADRA1ASLC6A2 | |
| SCHEMBL10411971 | 0.83 | TYR (0.71) | TRPA1LMNACHRM1ADRA1ASLC6A2 | |
| SCHEMBL14676983 | 0.81 | LMNA (0.53) | TRPA1LMNACHRM1ADRA1ASLC6A2 | |
| SCHEMBL28296896 | 0.81 | CHRM1 (0.43) | TRPA1LMNACHRM1ADRA1ASLC6A2 | |
| SCHEMBL51095 | 0.81 | CHRM1 (0.55) | TRPA1LMNACHRM1ADRA1ASLC6A2 | |
| SCHEMBL11410686 | 0.80 | CACNA2D1 (0.43) | LMNASLC6A2KMT2AHTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115541771-B | Method for detecting impurities of 2-benzhydryl-5-methylphenol and benzophenone hydrazone in tazobactam | 海南通用三洋药业有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-115541771-A | Method for detecting 2-benzhydryl-5-methylphenol and benzophenone hydrazone impurities in tazobactam | 海南通用三洋药业有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-115541771-B | Method for detecting impurities of 2-benzhydryl-5-methylphenol and benzophenone hydrazone in tazobactam | 海南通用三洋药业有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-115541771-B | Method for detecting impurities of 2-benzhydryl-5-methylphenol and benzophenone hydrazone in tazobactam | 海南通用三洋药业有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-115541771-B | Method for detecting impurities of 2-benzhydryl-5-methylphenol and benzophenone hydrazone in tazobactam | 海南通用三洋药业有限公司 | 2024-08-30 | — | — | CN | disclosed |
| US-20240025873-A1 | METHOD FOR PRODUCING KETONE DERIVATIVE | TOKUYAMA CORPORATION (JP) | 2024-01-25 | — | — | US | disclosed |
| EP-4249462-A1 | METHOD FOR PRODUCING KETONE DERIVATIVE | Tokuyama Corporation (JP) | 2023-09-27 | — | — | EP | disclosed |
| CN-115541771-A | Method for detecting 2-benzhydryl-5-methylphenol and benzophenone hydrazone impurities in tazobactam | 海南通用三洋药业有限公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-115541771-A | Method for detecting 2-benzhydryl-5-methylphenol and benzophenone hydrazone impurities in tazobactam | 海南通用三洋药业有限公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-115541771-A | Method for detecting 2-benzhydryl-5-methylphenol and benzophenone hydrazone impurities in tazobactam | 海南通用三洋药业有限公司 | 2022-12-30 | — | — | CN | disclosed |
| EP-0536710-B1 | Amino acid derivatives for peptide synthesis | BACHEM FEINCHEMIKALIEN AG (CH) | 1996-05-08 | — | — | EP | disclosed |
| US-5455363-A | Having trityl as amide-protecting group for asparagine and glutamine; reduced side reaction | GOSTELI JACQUES (CH) | 1995-10-03 | — | — | US | disclosed |
| EP-0536710-A1 | Amino acid derivatives for peptide synthesis | BACHEM FEINCHEMIKALIEN AG (CH) | 1993-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025873-A1 | METHOD FOR PRODUCING KETONE DERIVATIVE | HSD17B7, BCKDK, KARS1 | TRPA1 3574/4885LMNA 3073/4885CHRM1 4477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.